The estimated Net Worth of Edward Feuer is at least $9.14 mil dollars as of 4 March 2024. Edward Feuer owns over 1,000 units of Daxor stock worth over $9,140 and over the last 6 years he sold DXR stock worth over $0. In addition, he makes $0 as Director at Daxor.
Sign up
Edward Feuer DXR stock SEC Form 4 insiders trading
Edward has made over 2 trades of the Daxor stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of DXR stock worth $7,210 on 4 March 2024.
The largest trade he's ever made was buying 1,500 units of Daxor stock on 12 July 2018 worth over $9,270. On average, Edward trades about 313 units every 258 days since 2018. As of 4 March 2024 he still owns at least 1,000 units of Daxor stock.
You can see the complete history of Edward Feuer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Edward Feuer biography
Edward Feuer is the Director at Daxor.
What's Edward Feuer's mailing address?
Edward's mailing address filed with the SEC is 2 Wall St FL 10, New York, NY 10005, USA.
Insiders trading at Daxor
Over the last 21 years, insiders at Daxor have traded over $7,541,627 worth of Daxor stock and bought 473,408 units worth $2,888,339 . The most active insiders traders include Joseph Feldschuh, Bruce Slovin y Robert J Michel. On average, Daxor executives and independent directors trade stock every 39 days with the average trade being worth of $27,740. The most recent stock trade was executed by Robert J Michel on 27 March 2024, trading 750 units of DXR stock currently worth $6,525.
What does Daxor do?
the bva-100 (blood volume analyzer) is the first instrument of its kind that can precisely measure the amount of blood a patient has in their body. blood volume measurements have been available for almost 60 years, but the test often took 4 to 8 hours to perform and was very difficult to perform accurately. due to these issues, blood volume measurements were very rarely done. physicians had been forced to rely on substitute tests that were only able to measure the thickness of the blood and can be very misleading in many surgical and medical situations. the bva-100 can measure blood volume: accurately, quickly & reliably.
What does Daxor's logo look like?
Complete history of Edward Feuer stock trades at Daxor
Daxor executives and stock owners
Daxor executives and other stock owners filed with the SEC include:
-
Jonathan Adam Feldschuh,
Chief Scientific Officer & Director -
Michael Richard Feldschuh,
Chairman, Pres & CEO -
Diane Meegan,
IR Contact Officer -
Robert Willens,
Independent Director -
James Lombard,
Independent Director -
Joy Goudie,
Independent Director -
Edward Feuer,
Director -
Henry Cremisi,
Director -
Jonathan Feldschuh,
Chief Scientific Officer, Director -
Robert Michel,
Chief Financial Officer -
Michael Feldschuh,
Chairman of the Board, President, Chief Executive Officer -
Robert J. Michel M.B.A., CPA, CPA,
CFO, Chief Compliance Officer & Corp. Sec. -
Guido Manzo,
VP of Sales -
Kathryn A. Kornafel,
VP of Marketing & Commercial Devel. -
Robert J. Michel M.B.A., C.P.A., CPA,
CFO, Chief Compliance Officer & Corp. Sec. -
Caleb Des Rosiers,
Director -
Of Joseph Feldschuh Estate,
10% owner -
Bernhard Saxe,
Director -
Soren Thompson,
VP, Business Development -
Everis Engstrom,
Vice President -
Robert G Moussa,
Director -
Martin S Wolpoff,
Director -
Philip Nordan Hudson,
Director -
Joseph Feldschuh,
President & CEO -
Stephen Valentine,
Director -
Bruce Slovin,
Director -
Gary Joseph Fischman,
President